M. Ouali

发表

Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years.

J. Blay, M. van Glabbeke, M. Glabbeke, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group.

F. Bertucci, S. Salas, A. Italiano, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Is TOMPOOL (gated blood-pool SPECT processing software) accurate to diagnose right and left ventricular dysfunction in a clinical setting?

H. Rousseau, L. Dercle, R. Chisin, 2014, Journal of Nuclear Cardiology.

Are Peripheral Purely Undifferentiated Pleomorphic Sarcomas With MDM2 Amplification Dedifferentiated Liposarcomas?

F. Chibon, Gaëlle Pérot, P. Terrier, 2014, The American journal of surgical pathology.

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998).

S. Gwyther, J. D. de Jong, R. Keus, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.

M. van Glabbeke, M. Glabbeke, A. Cesne, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study.

S. Sleijfer, P. Rutkowski, P. Hohenberger, 2014, European journal of cancer.

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma

M. Macro, X. Leleu, T. Facon, 2018, Oncotarget.

Gated blood pool SPECT: The estimation of right ventricular volume and function is algorithm dependent in a clinical setting

H. Rousseau, L. Dercle, R. Chisin, 2015, Journal of Nuclear Cardiology.

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcom

S. Sleijfer, J. Blay, S. Rodenhuis, 2010, European journal of cancer.

review Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years

M. Glabbeke, P. Hohenberger, J. Blay, 2011 .

Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group

J. Blay, A. Le Cesne, S. Piperno-Neumann, 2015, BMC Cancer.

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG).

A. Ravaud, S. Culine, B. Escudier, 2015 .

Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: Are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?

Lawrence Dierickx, Slimane Zerdoud, Laurent Dercle, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

J. Blay, G. Demetri, A. Cesne, 2012, The Lancet.

Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.

J. Blay, R. Sciot, J. Wanders, 2011, The Lancet. Oncology.

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

J. Verweij, S. Bonvalot, F. van Coevorden, 2012, The Lancet. Oncology.

Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials.

Thomas Filleron, Murielle Mauer, Simone Mathoulin-Pélissier, 2013, European journal of cancer.

Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.

J. Blay, M. van Glabbeke, P. Hohenberger, 2013, European journal of cancer.

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S. Sleijfer, F. Collin, M. van Glabbeke, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.

J. Blay, S. Litière, J. Verweij, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†.

A. Ravaud, S. Culine, B. Escudier, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Statistical methodology for personalized medicine: New developments at EORTC Headquarters since the turn of the 21st Century

L. Collette, T. Gorlia, S. Litière, 2012 .

Achievements of the EORTC Soft Tissue and Bone Sarcoma Group

M. Glabbeke, P. Hohenberger, I. Judson, 2012 .

Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression

G. Ferron, J. Delord, B. Couderc, 2014, Journal of Ovarian Research.

PALETTE: A randomized, double-blind, phase III trial of pazopanib versus placebo in patients (pts) with soft-tissue sarcoma (STS) whose disease has progressed during or following prior chemotherapy-An EORTC STBSG Global Network Study (EORTC 62072).

J. Blay, A. Cesne, A. D. Dei Tos, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis.

F. Dalenc, T. Filleron, H. Roché, 2017, European journal of cancer.

Analysis of the quality of reporting surgical procedures in patients undergoing resection for primary gastrointestinal stromal tumors: A reporting tool derived from the EORTC–STBSG 62024 trial.

S. Bonvalot, P. Rutkowski, P. Hohenberger, 2012 .

Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment

A. Laprie, T. Filleron, L. Vieillevigne, 2014, Radiation oncology.

Dosimetric comparison of flattened and unflattened beams for stereotactic body radiation therapy: Impact of the size of the PTV on dynamic conformal arc and volumetric modulated arc therapy.

L. Vieillevigne, M. Ouali, C. Lanaspèze, 2016, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†.

A. Ravaud, S. Culine, B. Escudier, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic and predictive factors for outcome to first-line ifosfamide-containing therapy (IFM) in patients (pts) with advanced soft tissue sarcomas (STS) treated in EORTC-STBSG studies

S. Sleijfer, J. Blay, S. Rodenhuis, 2008 .

Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment

A. Laprie, T. Filleron, L. Vieillevigne, 2014, Radiation Oncology.